Financing, Equity Capital Markets

ImmunoVaccine (IMV, Inc.)

07/20
|
$30.0 Million
Piper Sandler served as bookrunner for ImmunoVaccine on an ATM offering
Sub-Type
At the Market Offering
Sub-Sector
Biopharma